文献速递糖尿病

VI型胶原形成增加与2型糖尿病合并微量白蛋白尿患者全因死亡率相关

Higher Collagen VI Formation Is Associated With All-Cause Mortality in Patients With Type 2 Diabetes and Microalbuminuria.
PubMed 文献 · Diabetes Care · 2018-04-11

一项前瞻性观察性研究纳入198例2型糖尿病合并微量白蛋白尿患者,中位随访6.5年。血清PRO-C6每翻倍,全因死亡风险比为6.91(95%CI 2.96-16.11),并将相对综合判别指数提高76.8%(P=0.002)。尿PRO-C6与任何结局均无显著关联。

要点

  • 血清PRO-C6每翻倍,全因死亡风险比为6.91(95%CI 2.96-16.11)。
  • 血清PRO-C6每翻倍,心血管事件风险比为3.06(95%CI 1.31-7.14)。
  • 尿PRO-C6与任何结局均无显著关联。

核心结论

  • 血清PRO-C6预测2型糖尿病合并微量白蛋白尿患者的心血管事件、全因死亡和疾病进展。

研究设计与样本

  • 前瞻性观察性研究,纳入198例无冠心病症状的2型糖尿病合并微量白蛋白尿患者,中位随访6.5年。

主要发现

  • 血清PRO-C6每翻倍,心血管事件风险比为3.06(95%CI 1.31-7.14),全因死亡风险比为6.91(95%CI 2.96-16.11),疾病进展风险比为4.81(95%CI 1.92-12.01)。
  • 将血清PRO-C6加入传统风险因素模型后,心血管事件的相对综合判别指数提高22.5%(P=0.02),全因死亡提高76.8%(P=0.002),疾病进展提高53.3%(P=0.004)。
  • 尿PRO-C6与任何结局均无显著关联。

关键数值与推荐

  • 血清PRO-C6每翻倍,心血管事件风险比为3.06(95%CI 1.31-7.14)。
  • 血清PRO-C6每翻倍,全因死亡风险比为6.91(95%CI 2.96-16.11)。
  • 血清PRO-C6每翻倍,疾病进展风险比为4.81(95%CI 1.92-12.01)。
  • 将血清PRO-C6加入传统风险因素模型后,心血管事件的相对综合判别指数提高22.5%(P=0.02)。
  • 将血清PRO-C6加入传统风险因素模型后,全因死亡的相对综合判别指数提高76.8%(P=0.002)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Type 2 diabetes is a common risk factor for the development of chronic kidney disease (CKD). Enhanced de novo collagen type VI (COL VI) formation has been associated with renal fibrosis and CKD. We investigated the hypothesis that PRO-C6, a product specifically generated during COL VI formation, is prognostic for adverse outcomes in patients with type 2 diabetes and microalbuminuria. RESEARCH DESIGN AND METHODS: In a prospective, observational study, we measured PRO-C6 in the serum (S-PRO-C6) and urine (U-PRO-C6) of 198 patients with type 2 diabetes and microalbuminuria without symptoms of coronary artery disease. Patients were followed for a median of 6.5 years, and end points were a composite of cardiovascular events (n = 38), all-cause mortality (n = 26), and reduction of estimated glomerular filtration rate (eGFR) of >30% (disease progression [n = 42]). Cox models were unadjusted and adjusted for the conventional risk factors of sex, age, BMI, systolic blood pressure, LDL cholesterol, smoking, HbA1c, plasma creatinine, and urinary albumin excretion rate. RESULTS: Doubling of S-PRO-C6 increased hazards for cardiovascular events (hazard ratio 3.06 [95% CI 1.31-7.14]), all-cause mortality (6.91 [2.96-16.11]), and disease progression (4.81 [1.92-12.01]). Addition of S-PRO-C6 to a model containing conventional risk factors improved relative integrated discrimination by 22.5% for cardiovascular events (P = 0.02), 76.8% for all-cause mortality (P = 0.002), and 53.3% for disease progression (P = 0.004). U-PRO-C6 was not significantly associated with any of the outcomes. CONCLUSIONS: S-PRO-C6 generated during COL VI formation predicts cardiovascular events, all-cause mortality, and disease progression in patients with type 2 diabetes and microalbuminuria.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Rasmussen DGK, Hansen TW, von Scholten BJ, et al. Higher Collagen VI Formation Is Associated With All-Cause Mortality in Patients With Type 2 Diabetes and Microalbuminuria. Diabetes Care. 2018. PMID: 29643059. doi:10.2337/dc17-2392

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。